Stocktoria
Amneal Pharmaceuticals, Inc. AMRX
Amneal Pharmaceuticals, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 11,282,430 | $71.6M | 3.47% |
| D. E. Shaw & Co., Inc. | 1,719,954 | $21.4M | 0.53% |
| AQR CAPITAL MANAGEMENT LLC | 864,792 | $10.7M | 0.27% |
| CITADEL ADVISORS LLC | 619,419 | $7.7M | 0.19% |
| MILLENNIUM MANAGEMENT LLC | 419,733 | $5.2M | 0.13% |
| TWO SIGMA INVESTMENTS, LP | 282,677 | $3.5M | 0.09% |
| RENAISSANCE TECHNOLOGIES LLC | 276,637 | $3.4M | 0.09% |
| Point72 Asset Management, L.P. | 78,105 | $970,845 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.